The adverse event profile of lacosamide: A systematic review and meta‐analysis of randomized controlled trials

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Epilepsia

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1528-1167.2012.03589.xPMID 22779776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pregabalin add-on for drug-resistant partial epilepsy.

  2019cited by this paper
• Tiagabine add-on for drug-resistant partial epilepsy.

  2014cited by this paper
• Topiramate add-on for drug-resistant partial epilepsy.

  2014cited by this paper
• Zonisamide add-on for drug-resistant partial epilepsy.

  2013cited by this paper
• The adverse event profile of pregabalin across different disorders: a meta-analysis

  2012influential reference
• 054 Can randomised controlled trial data from non-epilepsy indications be included in meta-analysis for AEDs used in epilepsy? An analysis of adverse event data

  2012cited by this paper
• Antiepileptic Drugs in Non-Epilepsy Disorders

  2012cited by this paper
• Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?

  2011cited by this paper
• The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trials

  2011influential reference
• Results can be summarised in a simple figure

  2011cited by this paper
• Add-on lacosamide: a retrospective study on the relationship between serum concentration, dosage, and adverse events.

  2011cited by this paper
• Adjunctive lacosamide in clinical practice: sodium blockade with a difference?

  2011cited by this paper
• Lacosamide‐induced second‐degree atrioventricular block in a patient with partial epilepsy

  2011cited by this paper
• Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures.

  2010cited by this paper
• Lacosamide: new adjunctive treatment option for partial-onset seizures

  2010cited by this paper
• Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy

  2010cited by this paper
• A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs

  2010cited by this paper
• Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy

  2010cited by this paper
• Mechanisms by Which Pharmacologic Agents May Contribute to Fatigue

  2010cited by this paper
• Randomized clinical trials in children--ethical and methodological issues.

  2010cited by this paper
• Lacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trial

  2010cited by this paper
• Adverse antiepileptic drug effects

  2009cited by this paper
• Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trial

  2009cited by this paper
• Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.

  2009cited by this paper
• Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain: An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens

  2009cited by this paper
• Pregabalin for the management of partial epilepsy

  2008cited by this paper
• The Investigational Anticonvulsant Lacosamide Selectively Enhances Slow Inactivation of Voltage-Gated Sodium Channels

  2008cited by this paper
• Vigabatrin for refractory partial epilepsy.

  2008cited by this paper
• Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.

  2008cited by this paper
• Topiramate add-on for drug-resistant partial epilepsy.

  2008cited by this paper
• Clobazam as an add-on in the management of refractory epilepsy.

  2008cited by this paper
• Pregabalin add-on for drug-resistant partial epilepsy.

  2008cited by this paper
• Idiosyncratic Adverse Reactions to Antiepileptic Drugs

  2007cited by this paper
• Lacosamide in Painful Diabetic Peripheral Neuropathy: A Phase 2 Double-blind Placebo-controlled Study

  2007cited by this paper
• Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset Seizures

  2007cited by this paper
• Reduced Sodium Current in Purkinje Neurons from NaV1.1 Mutant Mice: Implications for Ataxia in Severe Myoclonic Epilepsy in Infancy

  2007cited by this paper
• Zonisamide add-on for drug-resistant partial epilepsy.

  2005cited by this paper
• Adverse motor effects induced by antiepileptic drugs.

  2004cited by this paper
• Pregabalin Pharmacology and Its Relevance to Clinical Practice

  2004cited by this paper
• Remacemide for drug-resistant localization related epilepsy.

  2002cited by this paper
• How should meta‐regression analyses be undertaken and interpreted?

  2002cited by this paper
• Zonisamide add-on for drug-resistant partial epilepsy.

  2002cited by this paper
• Pooling, meta-analysis, and the evaluation of drug safety

  2002cited by this paper
• Topiramate add-on for drug-resistant partial epilepsy.

  2002cited by this paper
• Tiagabine add-on for drug-resistant partial epilepsy.

  2002cited by this paper
• Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review.

  2001cited by this paper
• Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.

  2001cited by this paper
• Zonisamide for drug-resistant partial epilepsy.

  2000cited by this paper
• Lamotrigine add-on for drug-resistant partial epilepsy.

  2000cited by this paper
• Gabapentin for drug-resistant partial epilepsy.

  2000cited by this paper
• Topiramate for drug-resistant partial epilepsy.

  2000cited by this paper
• The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability

  1997cited by this paper
• Quality of Life of People with Epilepsy: A European Study

  1997cited by this paper
• Adverse effects of anticonvulsant drugs--a critical review.

  1986influential reference
• [Randomized clinical trials].

  1982cited by this paper
• Correlation Between Daily Fluctuations of Carbamazepine Serum Levels and Intermittent Side Effects

  1980cited by this paper

• Saliva-based lacosamide monitoring paves the way toward personalized epilepsy pharmacotherapy

  2025cites this paper
• Exploring the Biomarkers and Potential Mechanisms of Botulinum Toxin Type A in the Treatment of Microglial Inflammatory Activation through P2X7 Receptors based on Transcriptome Sequencing.

  2024cites this paper
• An Retrospective Study of Commonly Prescribed Antiepileptic Drugs and it’s Interaction with Other Drugs which are Already in use Respect to Other Disease

  2024cites this paper
• Serious adverse effects of selected antiseizure medications used for treatment of focal onset seizures

  2024cites this paper
• Beyond the Pain: A Systematic Narrative Review of the Latest Advancements in Fibromyalgia Treatment

  2023cites this paper
• First add-on lacosamide treatment in children with focal epilepsy in China: A multi-centre real-life cohort study.

  2023cites this paper
• The safety of perampanel in different disorders and doses: A meta-analysis.

  2023cites this paper
• Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study

  2023cites this paper
• Epileptischer Anfall bei älteren Patienten

  2022cites this paper
• Cognitive Effects of Lacosamide in Patients with Drug Refractory Focal Epilepsy: A Prospective Observational Study

  2021cites this paper
• Drugs for patients with epilepsy and excessive daytime sleepiness.

  2021cites this paper
• Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy

  2021cites this paper
• COGNITIVE ADVERSE EFFECTS OF LACOSAMIDE IN PATIENTS WITH LOCALIZATION RELATED EPILEPSY - A PROSPECTIVE OBSERVATIONAL STUDY

  2021cites this paper
• Safety and Tolerability of Lacosamide in Patients With Epilepsy: A Systematic Review and Meta-Analysis

  2021cites this paper
• Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications.

  2021cites this paper
• Efficacy of lacosamide and phenytoin in status epilepticus: A systematic review

  2021cites this paper
• Cannabidiol Selectively Binds to the Voltage-Gated Sodium Channel Nav1.4 in Its Slow-Inactivated State and Inhibits Sodium Current

  2021cites this paper
• The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy.

  2020cites this paper
• Effects of Lacosamide in Rats with Lipopolysaccharide Induced Hepatic Pathology

  2020cites this paper
• Therapeutic monitoring of lacosamide in Japanese patients with epilepsy-Clinical response, tolerability, and optimal therapeutic range.

  2020cites this paper
• Cannabidiol improves survival and behavioural co‐morbidities of Dravet syndrome in mice

  2020cites this paper
• The adverse-effect profile of lacosamide

  2020cites this paper
• The tolerability and safety profile of eslicarbazepine acetate in neurological disorders.

  2020cites this paper
• The impact of lacosamide on mood disorders in adult patients with epilepsy: A systematic review.

  2020cites this paper
• Rashes and other hypersensitivity reactions associated with antiepileptic drugs: A review of current literature.

  2019cites this paper
• Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial

  2019cites this paper
• Clinical experience combined with therapeutic drug monitoring of lacosamide

  2019cites this paper
• Cannabidiol improves survivability, seizures and associated behavioural comorbidities in a range of animal models of epilepsy

  2019influential citation
• Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy.

  2018cites this paper
• Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.

  2018cites this paper
• Chronic treatment with the new anticonvulsant drug lacosamide impairs learning and memory processes in rats: A possible role of BDNF/TrkB ligand receptor system

  2018cites this paper
• Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models

  2018cites this paper
• Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.

  2018cites this paper
• Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors

  2018cites this paper
• HyperCKemia associated with lacosamide therapy in an elderly patient with focal onset epilepsy.

  2018cites this paper
• Farmacogenética de reacciones adversas a fármacos antiepilépticos

  2018cites this paper
• Tolerability of new antiepileptic drugs: a network meta-analysis

  2017cites this paper
• Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures

  2017cites this paper
• Retracted: A randomized controlled trial of lacosamide versus sodium valproate in status epilepticus

  2017cites this paper
• Intelligent use of antiepileptic drugs is beneficial to patients

  2017cites this paper
• Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study.

  2017cites this paper
• Therapeutic Advances in Neurological Disorders

  2017cites this paper
• Antiepileptic Drug-Related Ataxia in Children

  2017cites this paper
• Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability

  2017cites this paper
• Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.

  2016cites this paper
• Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial–the LENSS study

  2016cites this paper
• Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepine.

  2016cites this paper
• Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study.

  2016cites this paper
• 라코사마이드와 관련된 발프로산 독성 1례

  2016cites this paper
• Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies

  2015cites this paper
• Pharmacogenetics of adverse reactions to antiepileptic drugs.

  2015cites this paper
• Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy

  2015influential citation
• Lacosamide as adjunctive therapy in treatment‐resistant epilepsy in childhood

  2015cites this paper
• The adverse event profile of levetiracetam: A meta-analysis on children and adults.

  2015influential citation
• Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.

  2015cites this paper
• Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: An extended follow-up.

  2015cites this paper
• A systematic review of placebo‐controlled trials of topiramate: How useful is a multiple‐indications review for evaluating the adverse events of an antiepileptic drug?

  2015cites this paper
• Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy

  2015cites this paper
• SEIZURE DISORDER WITH LEVETIRACETAM INDUCED PSYCHOSIS - A CASE REPORT

  2015cites this paper
• Prevention and Management of Side‐effects of Antiepileptic Drugs

  2015cites this paper
• Sodium channel slow inactivation as a therapeutic target for myotonia congenita

  2015cites this paper
• Two definite cases of sudden unexpected death in epilepsy in a family with a DEPDC5 mutation

  2015cites this paper
• Lacosamide-induced acute pancreatitis with positive rechallenge test.

  2014cites this paper
• Successful treatment with adjunctive lacosamide in a patient with long term “drug resistant” focal epilepsy

  2014cites this paper
• Hospital discharges for Crohn's disease in States with high smoking prevalence.

  2014cites this paper
• Lacosamide for the treatment of epilepsy

  2014cites this paper
• Lacosamide-induced tactile hallucinations in a patient with complex partial seizures.

  2014cites this paper
• Recurrent Bell's palsy in a patient with Crohn's disease on methotrexate.

  2014cites this paper
• Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double‐blind, noninferiority trial

  2014cites this paper
• Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective

  2014cites this paper
• Chapter 7 - Antiepileptic Drugs

  2014cites this paper
• Proton modulation of cardiac I Na: a potential arrhythmogenic trigger.

  2014cites this paper
• Effect of lacosamide on structural damage and functional recovery after traumatic brain injury in rats.

  2014cites this paper
• Lacosamide-induced rash.

  2014cites this paper
• Safe Treatment of Seizures in the Setting of HIV/AIDS

  2013cites this paper
• The Long-Term Safety of Antiepileptic Drugs

  2013cites this paper
• The adverse event profile of perampanel: meta‐analysis of randomized controlled trials

  2013cites this paper
• The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.

  2013cites this paper
• Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.

  2013cites this paper
• Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.

  2013cites this paper
• Lacosamide Therapeutic Monitoring in Patients With Epilepsy: Effect of Concomitant Antiepileptic Drugs

  2013cites this paper
• Lacosamide in patients with pharmacoresistant epilepsy

  2012cites this paper
• Changes in Learning and Memory in Pentylenetetrazole Induced Amnesia of Rats Treated with Lacosamide

  2011cites this paper
• Newer Antiepileptic Drugs : Pharmacokinetics , Dosage , Major Side Effects , Drug Interactions

  year unknowncites this paper
• Annals of the New York Academy of Sciences Development of Lacosamide for the Treatment of Partial-onset Seizures

  year unknowncites this paper